---
schema_version: "secwatch.filing_event.v1"
accession: "0001575872-22-000476"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2022-05-27T23:59:59+00:00"
generated_at: "2026-06-25T06:28:21.445332+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Denali Capital Acquisition Corp. announces separate trading of Class A shares and warrants starting May 31, 2022

## Summary
- Units from IPO of 8,250,000 units may be separated into Class A ordinary shares and warrants effective May 31, 2022.
- Each unit consists of one Class A ordinary share and one redeemable warrant to purchase one Class A share at $11.50.
- Separated shares trade under DECA and warrants under DECAW; units remain under DECAU on Nasdaq.
- No fractional warrants will be issued; holders must contact transfer agent VStock Transfer to separate units.
- Joint book-runners were US Tiger Securities, Inc. and EF Hutton; Craig-Hallum acted as qualified independent underwriter.

## SEC filing metadata
- accession: 0001575872-22-000476
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2022-05-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000157587222000476/0001575872-22-000476-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000157587222000476/deca-20220526.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001575872-22-000476
- JSON: https://secwatch.observer/filing/0001575872-22-000476.json
- Plain text: https://secwatch.observer/filing/0001575872-22-000476.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.